CN108727464A - A kind of new Protein Extraction Reagent and method - Google Patents
A kind of new Protein Extraction Reagent and method Download PDFInfo
- Publication number
- CN108727464A CN108727464A CN201810577627.1A CN201810577627A CN108727464A CN 108727464 A CN108727464 A CN 108727464A CN 201810577627 A CN201810577627 A CN 201810577627A CN 108727464 A CN108727464 A CN 108727464A
- Authority
- CN
- China
- Prior art keywords
- protein
- cells
- add
- protein extraction
- tris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000751 protein extraction Methods 0.000 title claims abstract description 31
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004471 Glycine Substances 0.000 claims abstract description 8
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000011187 glycerol Nutrition 0.000 claims abstract description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims abstract description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000007983 Tris buffer Substances 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 71
- 108090000623 proteins and genes Proteins 0.000 claims description 71
- 239000000284 extract Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 230000001464 adherent effect Effects 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 238000001262 western blot Methods 0.000 abstract description 20
- 238000001514 detection method Methods 0.000 abstract description 12
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 53
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 17
- 239000006166 lysate Substances 0.000 description 13
- 210000003954 umbilical cord Anatomy 0.000 description 11
- 102000007469 Actins Human genes 0.000 description 10
- 108010085238 Actins Proteins 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000006180 TBST buffer Substances 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 6
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 210000004748 cultured cell Anatomy 0.000 description 5
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 4
- 101000844518 Homo sapiens Transient receptor potential cation channel subfamily M member 7 Proteins 0.000 description 4
- 102100037850 Interferon gamma Human genes 0.000 description 4
- 108010074328 Interferon-gamma Proteins 0.000 description 4
- 102000003611 TRPM7 Human genes 0.000 description 4
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 4
- 238000002331 protein detection Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- DDOQBQRIEWHWBT-UHFFFAOYSA-N 2-azaniumyl-4-phosphonobutanoate Chemical compound OC(=O)C(N)CCP(O)(O)=O DDOQBQRIEWHWBT-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 101150045183 TRPM7 gene Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供了一种蛋白提取试剂,每10ml水溶液中包括以下组分:Tris 14.5~15.5mg、甘氨酸74~75mg、SDS 202‑208mg、溴酚兰10~12mg、Tris‑HCl 0.5~0.6ml、甘油0.8~1.2ml、β‑巯基乙醇0.4‑0.6ml。本发明不仅解决了微量细胞的检测问题,提高了Western blot的检测灵敏度。
The invention provides a protein extraction reagent, which includes the following components per 10ml of aqueous solution: Tris 14.5-15.5mg, glycine 74-75mg, SDS 202-208mg, bromophenol blue 10-12mg, Tris-HCl 0.5-0.6ml, Glycerin 0.8~1.2ml, β-mercaptoethanol 0.4-0.6ml. The invention not only solves the detection problem of trace cells, but also improves the detection sensitivity of Western blot.
Description
技术领域technical field
本发明属于生物技术领域,涉及蛋白提取。The invention belongs to the field of biotechnology and relates to protein extraction.
背景技术Background technique
Western blot(蛋白印迹)在科研行业中是检测蛋白最重要的实验方法,只要涉及到蛋白检测,首选一定是Western blot。Western blot是分子生物学、生物化学和免疫遗传学中常用的一种实验方法。其基本原理是通过特异性抗体对凝胶电泳处理过的细胞或生物组织蛋白样品进行着色。通过分析着色的位置和着色深度获得特定蛋白质在所分析的细胞或组织中表达情况的信息。它是最常用的也是最重要的蛋白检测技术。但是在进行Westernblot之前,必须提取细胞或生物组织的总蛋白。Western blot是以提取的总蛋白为检测对象的一门实验技术。Western blot (Western blot) is the most important experimental method for protein detection in the scientific research industry. As long as protein detection is involved, Western blot must be the first choice. Western blot is an experimental method commonly used in molecular biology, biochemistry and immunogenetics. The basic principle is to stain the gel electrophoresis-treated cells or biological tissue protein samples through specific antibodies. Information about the expression of specific proteins in the analyzed cells or tissues can be obtained by analyzing the location and depth of staining. It is the most commonly used and most important protein detection technique. However, before performing Western blot, the total protein of cells or biological tissues must be extracted. Western blot is an experimental technique that uses the extracted total protein as the detection object.
一般来说,生物组织的总蛋白是比较好提取的,因为组织量够多,所以提取的总蛋白量够多、总蛋白浓度够高。但是培养细胞的总蛋白提取就不是这么容易。因为Westernblot对提取的总蛋白量和浓度都有要求。培养的细胞其本身蛋白量远少于组织中的蛋白量,即便加传统裂解液可以提出总蛋白,但是蛋白浓度常常不足以被Western blot检测出来。这种时候想要提高蛋白浓度,可以减少裂解液的用量,但是减少裂解液后,提取的总蛋白量又会降低,浓度达到而蛋白量不足也不能进行Western blot实验。因此,为了保证培养细胞的蛋白量和浓度。就只有增加培养细胞的数量。传统实验方法中,最好的情况也至少需要6孔板中2个孔的蛋白量才足以做Western blot。Generally speaking, the total protein of biological tissue is easier to extract, because the amount of tissue is enough, so the total protein extracted is large enough and the total protein concentration is high enough. But the total protein extraction of cultured cells is not so easy. Because Westernblot has requirements for the total protein amount and concentration extracted. The amount of protein in cultured cells is far less than that in tissues. Even if the total protein can be extracted by adding traditional lysate, the protein concentration is often not enough to be detected by Western blot. At this time, if you want to increase the protein concentration, you can reduce the amount of lysate, but after reducing the lysate, the total protein amount extracted will decrease, and the Western blot experiment cannot be performed if the concentration reaches the insufficient protein amount. Therefore, in order to ensure the protein amount and concentration of cultured cells. Just increase the number of cultured cells. In the traditional experimental method, in the best case, at least 2 wells of a 6-well plate are required to have enough protein for Western blot.
大部分实际操作中,一般会用到6孔板中3到4个孔的蛋白量。这种细胞量的增加最直接的会增加我们的实验材料成本和人工成本。其次,这种情况会消耗更多资源,产生更多垃圾和有害品,对环境保护极不利。再者,由于需要的细胞量大,在对细胞做处理时难免增加操作误差,影响实验结果。最后,也是最重要的,对于很多种细胞特别是原代细胞、罕见细胞、新培育细胞、珍贵细胞、非增殖细胞等我们在实验时,根本得不到传统提取蛋白所需要的蛋白量,无法进行Western blot。所以我们急需一种新的高效提取总蛋白方法来解决这些问题。In most practical operations, the amount of protein in 3 to 4 wells of a 6-well plate is generally used. This increase in the amount of cells will most directly increase our experimental material costs and labor costs. Secondly, this situation will consume more resources and generate more garbage and harmful products, which is extremely detrimental to environmental protection. Furthermore, due to the large amount of cells required, it is inevitable to increase operational errors when processing the cells, which will affect the experimental results. Finally, and most importantly, for many kinds of cells, especially primary cells, rare cells, newly cultivated cells, precious cells, non-proliferating cells, etc., we cannot obtain the amount of protein required by traditional protein extraction at all during experiments, and cannot Perform Western blot. So we urgently need a new and efficient method for extracting total protein to solve these problems.
发明内容Contents of the invention
本发明的目的在于提供一种新的蛋白提取试剂,这不仅解决了微量细胞的检测问题,还提高了Western blot的检测灵敏度。The purpose of the present invention is to provide a new protein extraction reagent, which not only solves the detection problem of trace cells, but also improves the detection sensitivity of Western blot.
本发明的目的是通过以下措施实现的:The object of the present invention is achieved by the following measures:
一种蛋白提取试剂,每10ml水溶液中包括以下组分:Tris(三羟甲基氨基甲烷)14.5~15.5mg、甘氨酸74~75mg、SDS 202-208mg、溴酚兰10~12mg、Tris-HCl 0.5~0.6ml、甘油0.8~1.2ml、β-巯基乙醇0.4-0.6ml。A protein extraction reagent, including the following components per 10ml of aqueous solution: Tris (trishydroxymethylaminomethane) 14.5-15.5mg, glycine 74-75mg, SDS 202-208mg, bromophenol blue 10-12mg, Tris-HCl 0.5 ~0.6ml, glycerin 0.8~1.2ml, β-mercaptoethanol 0.4-0.6ml.
优选的,上述蛋白提取试剂中各组分的最佳配比为:每10ml水溶液中含有以下组分:Tris 15mg、甘氨酸75mg、SDS 205mg、溴酚兰10mg、pH6.8的Tris-HCl0.5ml、甘油1ml、β-巯基乙醇0.5ml。Preferably, the optimal ratio of each component in the above protein extraction reagent is: each 10ml aqueous solution contains the following components: Tris 15mg, glycine 75mg, SDS 205mg, bromophenol blue 10mg, Tris-HCl of pH 6.8 0.5ml , glycerol 1ml, β-mercaptoethanol 0.5ml.
上述蛋白提取试剂用量为每1x106细胞加入400μL~600μL;或者24孔板每孔加200μL~300μL。The dosage of the above protein extraction reagent is 400 μL-600 μL per 1×10 6 cells; or 200 μL-300 μL per well of a 24-well plate.
本发明的另一目的在于提供采用上述试剂提取蛋白的方法。Another object of the present invention is to provide a method for extracting protein using the above reagents.
一种蛋白提取方法,包括以下步骤:A protein extraction method, comprising the following steps:
(1)收集细胞,清洗后按照每1x106细胞加入400μL~600μL所述蛋白提取试剂;(1) Collect the cells, add 400 μL to 600 μL of the protein extraction reagent per 1×10 6 cells after washing;
(2)静止30秒到2分钟;(2) Stand still for 30 seconds to 2 minutes;
(3)煮沸10~20分钟使蛋白变性,冷却。(3) Boil for 10-20 minutes to denature the protein, then cool.
具体的,上述蛋白提取试剂的使用方法,包括以下步骤:Specifically, the method for using the above-mentioned protein extraction reagent includes the following steps:
(1)配制蛋白提取试剂:按比例加入Tris、甘氨酸、SDS、溴酚兰、Tris-HCI、甘油、β-巯基乙醇、水;(1) Prepare protein extraction reagent: add Tris, glycine, SDS, bromophenol blue, Tris-HCl, glycerol, β-mercaptoethanol, water in proportion;
(2)对于贴壁细胞:去除培养液,用缓冲液洗,按照24孔板每孔加入200μL~300μL所述试剂;轻轻吹打混匀,使提取液和细胞充分接触;对于悬浮细胞:离心收集细胞,打散细胞,按照24孔板每孔细胞加入200μL~300μL,轻轻吹打混匀,使提取液和细胞充分接触;(2) For adherent cells: remove the culture medium, wash with buffer solution, add 200 μL to 300 μL of the above reagent per well of a 24-well plate; gently blow and mix to make the extract fully contact with the cells; for suspension cells: centrifuge Collect the cells, break up the cells, add 200 μL to 300 μL to each well of the 24-well plate, and gently blow and mix to make the extract fully contact with the cells;
(3)100℃或沸水浴加热15分钟,以充分变性蛋白;蛋白变性后存于-20℃,待western上样用。SDS-PAGE每孔上样量设20微升。样本可保存一年。(3) Heating at 100°C or in a boiling water bath for 15 minutes to fully denature the protein; store the denatured protein at -20°C until western loading. The loading volume of each well of SDS-PAGE was set at 20 microliters. Samples can be stored for one year.
按照以上步骤24孔板每孔可以做10次western。换算下来新方法只需传统方法八十分之一的蛋白量。According to the above steps, 10 westerns can be performed per well of a 24-well plate. In conversion, the new method only needs one-eightyth of the protein amount of the traditional method.
有益效果Beneficial effect
1.传统提取蛋白最大的问题在于要培养大量细胞,但不是所有细胞都可以进行大量培养,对于微量的细胞传统方法不能提取到有效总蛋白量。但本发明只需要传统方法的八十分之一的蛋白量即可,这不仅解决了微量细胞的的检测问题,也提高了Western blot的检测灵敏度。1. The biggest problem with traditional protein extraction is that a large number of cells need to be cultured, but not all cells can be cultured in large quantities, and the traditional method cannot extract effective total protein for a small amount of cells. However, the present invention only needs one eightyth of the protein amount of the traditional method, which not only solves the detection problem of trace cells, but also improves the detection sensitivity of Western blot.
2.本发明不仅对不能大量培养的细胞有帮助,提高了蛋白检测的灵敏度;对正常培养的细胞蛋白检测也有帮助。首先,由于细胞用量很少,一个检测组只需要24孔板一个孔的细胞,所以可以减少对细胞的培养,节约了时间和金钱成本;其次,24孔板一个孔的细胞量加200微升新蛋白上样液,足够做10次Western blot,保证了重复检测用量,提高了Western blot的检测准确性。2. The invention is not only helpful to cells that cannot be cultured in large quantities, but also improves the sensitivity of protein detection; it is also helpful to the detection of protein in normally cultured cells. First of all, due to the small amount of cells, a detection group only needs cells in one well of a 24-well plate, so it can reduce the cultivation of cells, saving time and money costs; The new protein sample solution is enough to do 10 times of Western blot, which ensures the amount of repeated detection and improves the detection accuracy of Western blot.
3.本发明步骤简单易操作,只需要几分钟即可提取完成。本发明简化了实验步骤,使得实验操作误差率降低。同样的样本处理,本发明在蛋白裂解环节只需要一两分钟,而老方法需要在冰上操作30分钟以上,时间大大减少。由于时间的减少也就不需要全程在冰上操作,简化了实验准备。3. The steps of the present invention are simple and easy to operate, and it only takes a few minutes to complete the extraction. The invention simplifies the experimental steps and reduces the experimental operation error rate. For the same sample processing, the present invention only needs one or two minutes in the protein cleavage link, while the old method needs to operate on ice for more than 30 minutes, and the time is greatly reduced. Due to the reduction of time, there is no need to operate on ice all the time, which simplifies the experimental preparation.
4.在传统提取蛋白中,提取蛋白后有些操作者会对蛋白进行浓度检测,再根据浓度再调整裂解液量,使得同批次不同组的上样总蛋白保持同浓度,这样Western blot跑出来的不同样本间的内参β-actin理论上是一致的,目的蛋白的差异显得比较一目了然,它的好处是方便直观看图判断结果,但定量分析结果跟这个操作没有必然关系。并且在实际操作中,内参还是不可能做到一样,常常跑出来参差不齐。针对这个差异,发明者提供两个参考解决方案。第一种方案是在新方法提取蛋白后用OD-1000或者OD-2000分光光度计直接测蛋白浓度,从而确定上样量,统一内参。但发明者更推荐方案二。方案二直接减去蛋白浓度检测这一步,减少操作步骤和时间,用另一种方法维持内参统一。具体步骤是在细胞培养铺板时,进行细胞计数,使得每孔种下的细胞数一样,那么每孔细胞的总蛋白量在种下是就决定了是一样的,跑出来的内参也就是大致一样的。如果蛋白跑出来的内参差异很大,可以调整上样量使得内参整齐,使得结果便于观察。4. In traditional protein extraction, some operators will detect the concentration of the protein after protein extraction, and then adjust the amount of lysate according to the concentration, so that the total protein loaded in different groups of the same batch remains at the same concentration, so that the Western blot will run out The internal reference β-actin between different samples is theoretically consistent, and the difference of the target protein is relatively clear at a glance. Its advantage is that it is convenient to judge the results by visually viewing the graph, but the quantitative analysis results are not necessarily related to this operation. And in actual operation, it is still impossible to achieve the same internal reference, and it often comes out uneven. For this difference, the inventor provides two reference solutions. The first solution is to directly measure the protein concentration with an OD-1000 or OD-2000 spectrophotometer after the protein is extracted by the new method, so as to determine the loading amount and unify the internal reference. But the inventor recommends option two more. Scheme 2 directly subtracts the step of protein concentration detection, reduces operation steps and time, and uses another method to maintain the unity of the internal reference. The specific steps are to count the cells when the cells are cultured and plated, so that the number of cells planted in each well is the same, then the total protein amount of the cells in each well is determined to be the same when the cells are planted, and the internal reference that comes out is approximately the same. If there is a big difference in the internal reference of the protein released, you can adjust the sample volume to make the internal reference neat, making the results easier to observe.
5.本发明蛋白提取完整,从15KD到22KD为例,都可完整提取并检测出来,完全可以代替传统试剂和方法。5. The protein of the present invention is completely extracted, from 15KD to 22KD as an example, can be completely extracted and detected, and can completely replace traditional reagents and methods.
6.本发明对细胞状态要求不高。不论是加药还是物理机械处理都可以高效完整提取蛋白。在实际实验中,经过各种处理细胞状态有好有坏,增殖能力很多开始下降,甚至细胞开始衰老凋亡加剧,但无论何种状态的细胞本发明都可以高效完整提取。6. The present invention does not have high requirements on the cell state. Whether it is drug addition or physical and mechanical treatment, protein can be extracted efficiently and completely. In the actual experiment, after various treatments, the state of the cells is good or bad, and many of the proliferative ability begins to decline, and even the cells begin to senescence and apoptosis intensifies, but the present invention can efficiently and completely extract the cells no matter what state.
7.本发明适用于各种细胞。无论是人源细胞还是鼠源细胞为例都可以提取。即使是原代细胞,培养难度很高,也可以完整提取蛋白。7. The present invention is applicable to various cells. Both human-derived cells and mouse-derived cells can be extracted. Even primary cells, which are difficult to cultivate, can still extract proteins intact.
8.本发明效率更高。传统方法需要原始细胞量大;而本发明需要细胞量低。传统方法是把蛋白从细胞中剥离出来,提取不完整;本发明是不需要分离蛋白质和细胞其他成分,得到的蛋白质更完整,实验结果更准确有效。传统方法提取量不高;本发明提取完整量充足。8. The efficiency of the present invention is higher. The traditional method requires a large amount of original cells; while the present invention requires a low amount of cells. The traditional method is to strip the protein from the cells, and the extraction is incomplete; the present invention does not need to separate the protein and other components of the cell, the obtained protein is more complete, and the experimental results are more accurate and effective. The extraction amount of the traditional method is not high; the extraction amount of the present invention is sufficient.
附图说明Description of drawings
图1本发明用于IFN-γ刺激人脐带间充质干细胞Fig. 1 The present invention is used for stimulating human umbilical cord mesenchymal stem cells by IFN-γ
图2本发明用于LIPUS及2-APB作用于小鼠骨髓间充质干细胞Figure 2 The present invention uses LIPUS and 2-APB to act on mouse bone marrow mesenchymal stem cells
图3β-actin对比新老方法提蛋白效果差异Figure 3 β-actin compares the difference in protein extraction effect between the old and new methods
具体实施方式Detailed ways
下面通过实施例对本发明进行具体的描述,有必要在此指出的是以下实施例只用于对本发明进行进一步说明,不能理解为对本发明保护范围的限制,该领域技术人员可以根据上述本发明内容对本发明作出一些非本质的改进和调整。The present invention is specifically described below through the examples, it is necessary to point out that the following examples are only used to further illustrate the present invention, and can not be interpreted as limiting the protection scope of the present invention, those skilled in the art can according to the content of the present invention above Some non-essential improvements and adjustments are made to the present invention.
实施例1Example 1
一种蛋白提取试剂,称取Tris 14.5~15.5mg、甘氨酸74~75mg、SDS 205mg、溴酚兰10~12mg、Tris-HCI(pH6.8)0.5~0.6ml、甘油0.8~1.2ml、β-巯基乙醇0.5ml、加入去离子水定容至10ml。-20℃可保存一年。A protein extraction reagent, weighing Tris 14.5~15.5mg, glycine 74~75mg, SDS 205mg, bromophenol blue 10~12mg, Tris-HCI (pH6.8) 0.5~0.6ml, glycerol 0.8~1.2ml, β- Mercaptoethanol 0.5ml, add deionized water to make up to 10ml. It can be stored for one year at -20°C.
1.所述蛋白提取试剂用于IFN-γ刺激人脐带间充质干细胞1. The protein extraction reagent is used for IFN-γ stimulation of human umbilical cord mesenchymal stem cells
(1)分离原代人脐带间充质干细胞。培养到第三代原代人脐带间充质干细胞。(1) Isolation of primary human umbilical cord mesenchymal stem cells. Cultured to the third generation of primary human umbilical cord mesenchymal stem cells.
(2)24孔板中每孔加入1x105个人脐带间充质干细胞,贴壁后再加入不同浓度IFN-γ(一种药物,能刺激目的细胞分泌相关蛋白因子),IFN-γ浓度分别为0ng/ml、20ng/ml、5ng/ml0、100ng/ml。培养48小时候准备收集细胞蛋白。( 2 ) Add 1x105 human umbilical cord mesenchymal stem cells to each well of a 24-well plate, and then add different concentrations of IFN-γ (a drug that can stimulate target cells to secrete related protein factors) after adhering to the wall. The concentrations of IFN-γ are respectively 0ng/ml, 20ng/ml, 5ng/ml0, 100ng/ml. Cellular proteins were ready to be harvested after 48 hours of culture.
(3)去除培养基,缓冲液清洗3次,按照24孔板每孔加200μL蛋白提取试剂,轻轻吹打混匀,静止1分钟,液体装入EP管。煮沸15分钟,使蛋白变性。冷却后放-20℃冻存。(3) Remove the medium, wash with buffer three times, add 200 μL of protein extraction reagent to each well of a 24-well plate, gently blow and mix, let stand for 1 minute, and put the liquid into an EP tube. Boil for 15 minutes to denature the egg whites. After cooling, store at -20°C.
(4)提取蛋白后,Western blot检测人脐带间充质干细胞中的目的蛋白分子表达量。检测了蛋白质β-actin、LC3、P62、Beclin。每组取20uL蛋白,电转法将蛋白质转移至PVDF膜上,TBST洗5次,每次3min;5%脱脂奶粉室温封闭1h,加入β-actin抗体、LC3、P62、Beclin抗体(1:1000稀释),4℃孵育过夜,TBST洗5次,每次3min,再加入二抗,室温孵育4h后TBST洗涤5次,每次3min,化学发光法显色。(4) After the protein was extracted, Western blot was used to detect the expression level of the target protein molecule in the human umbilical cord mesenchymal stem cells. Proteins β-actin, LC3, P62, Beclin were detected. Take 20uL protein from each group, transfer the protein to PVDF membrane by electroporation, wash 5 times with TBST, 3min each time; ), incubated overnight at 4°C, washed 5 times with TBST, 3 min each time, then added secondary antibody, incubated at room temperature for 4 h, washed 5 times with TBST, 3 min each time, and developed color by chemiluminescence.
实验结果见图1。其中β-actin蛋白分子量是45KD、LC3蛋白分子量是15KD、P62蛋白分子量是62KD、Beclin蛋白分子量是60KD。蛋白质的分子量一般在10到250KD之间,LC3分子量15KD可以代表小分子量蛋白质的提取能力,其他蛋白可以代表中等分子量的蛋白提取能力。(anti-LC3抗体美国CST公司、anti-Beclin1抗体美国abcam公司、anti-P62抗体美国sigma公司、β-actin美国sigma公司)The experimental results are shown in Figure 1. Among them, the molecular weight of β-actin protein is 45KD, the molecular weight of LC3 protein is 15KD, the molecular weight of P62 protein is 62KD, and the molecular weight of Beclin protein is 60KD. The molecular weight of protein is generally between 10 and 250KD, LC3 molecular weight of 15KD can represent the extraction ability of small molecular weight proteins, and other proteins can represent the extraction ability of medium molecular weight proteins. (anti-LC3 antibody US CST company, anti-Beclin1 antibody US abcam company, anti-P62 antibody US sigma company, β-actin US sigma company)
2.所述蛋白提取试剂用于LIPUS作用于小鼠骨髓间充质干细胞2. The protein extraction reagent is used for LIPUS to act on mouse bone marrow mesenchymal stem cells
(1)分离原代小鼠骨髓间充质干细胞。培养到第三代。(1) Isolation of primary mouse bone marrow mesenchymal stem cells. Cultivated to the third generation.
(2)24孔板中每孔加入1x105个小鼠骨髓间充质干细胞,贴壁后用低强度聚焦超声(LIPUS)处理细胞,培养48小时候准备收集细胞蛋白。( 2 ) 1x105 mouse bone marrow mesenchymal stem cells were added to each well of a 24-well plate, and the cells were treated with low-intensity focused ultrasound (LIPUS) after attachment, and cell proteins were ready to be collected after 48 hours of culture.
(3)去除培养基,缓冲液清洗3次,按照24孔板每孔加200μL提取液,轻轻吹打混匀,静止1分钟,液体装入EP管。煮沸15分钟,使蛋白变性。冷却后放-20℃冻存。(3) Remove the culture medium, wash with the buffer solution 3 times, add 200 μL extract solution to each well of the 24-well plate, gently blow and mix, let stand for 1 minute, and put the liquid into the EP tube. Boil for 15 minutes to denature the egg whites. After cooling, store at -20°C.
(4)提取蛋白后,Western blot检测小鼠骨髓间充质干细胞中的目的蛋白分子表达量。检测了蛋白质GAPDH、TRPM7。每组取20uL蛋白,电转法将蛋白质转移至PVDF膜上,TBST洗5次,每次3min;5%脱脂奶粉室温封闭1h,加入GAPDH、TRPM7抗体(1∶1000稀释),4℃孵育过夜,TBST洗5次,每次3min,再加入二抗,室温孵育4h后TBST洗涤5次,每次3min,化学发光法显色。(4) After the protein was extracted, Western blot was used to detect the expression level of the target protein molecule in the mouse bone marrow mesenchymal stem cells. The proteins GAPDH, TRPM7 were detected. Take 20uL protein from each group, transfer the protein to PVDF membrane by electroporation, wash 5 times with TBST, 3min each time; block with 5% skimmed milk powder at room temperature for 1h, add GAPDH, TRPM7 antibody (1:1000 dilution), incubate overnight at 4°C, Wash 5 times with TBST, 3 min each time, then add secondary antibody, incubate at room temperature for 4 h, wash 5 times with TBST, 3 min each time, develop color by chemiluminescence.
实验结果见图2。图2是LIPUS作用于小鼠骨髓间充质干细胞,检测的Trpm7蛋白分子量是220KD、GAPDH蛋白分子量是36KD。蛋白质的分子量一般在10到250KD之间,TRPM7分子量220KD可以代表大分子量蛋白质的提取能力。(GAPDH美国santa cruz、TRPM7英国Abcam)The experimental results are shown in Figure 2. Figure 2 shows the effect of LIPUS on mouse bone marrow mesenchymal stem cells. The detected molecular weight of Trpm7 protein is 220KD, and the molecular weight of GAPDH protein is 36KD. The molecular weight of protein is generally between 10 and 250KD, and the molecular weight of TRPM7 is 220KD, which can represent the extraction ability of large molecular weight proteins. (GAPDH US Santa Cruz, TRPM7 UK Abcam)
3.所述蛋白提取试剂通过β-actin对比新老方法提蛋白差异3. The protein extraction reagent extracts protein difference by β-actin comparing old and new methods
(1)分离原代人脐带间充质干细胞。培养到第三代原代人脐带间充质干细胞。(1) Isolation of primary human umbilical cord mesenchymal stem cells. Cultured to the third generation of primary human umbilical cord mesenchymal stem cells.
(2)T25培养瓶中加入8x105个人脐带间充质干细胞;24孔板中每孔加入1x105个人脐带间充质干细胞。培养48小时候准备收集细胞蛋白。( 2 ) 8x105 human umbilical cord mesenchymal stem cells were added to a T25 culture flask; 1x105 human umbilical cord mesenchymal stem cells were added to each well of a 24-well plate. Cellular proteins were ready to be harvested after 48 hours of culture.
(3)本发明方法:去除培养基,缓冲液清洗3次,按照24孔板每孔加200μL实施例1所述蛋白提取试剂,轻轻吹打混匀,静止1分钟,液体装入EP管。(3) The method of the present invention: remove the culture medium, wash with buffer 3 times, add 200 μL of the protein extraction reagent described in Example 1 to each well of a 24-well plate, gently blow and beat to mix, stand still for 1 minute, and put the liquid into an EP tube.
传统方法:提取一个T25培养瓶中的总蛋白,操作如下:因为提取时间过长防止蛋白降解全程在冰上操作。融解RIPA裂解液,混匀。取适当量的裂解液,在使用前数分钟内加入PMSF(蛋白酶抑制剂),使PMSF的最终浓度为1mM。去除培养液,用缓冲液洗三遍。按照6孔板每孔加入40微升裂解液的比例加入裂解液,即T25每瓶加100微升裂解液。用枪吹打数下,使裂解液和细胞充分接触。混匀震荡放于冰上裂解,每隔10min反复震荡混匀,共3次。充分裂解后,10000g离心5分钟,取上清80微升。溶解SDS-PAGE上样缓冲液(5X)。80微升裂解液加入20微升SDS-PAGE上样缓冲液(5X)。其中,所需全部试剂RIPA裂解液、PMSF、SDS-PAGE上样缓冲液(5X)都是可购商品。Traditional method: extract the total protein in a T25 culture flask, the operation is as follows: because the extraction time is too long to prevent protein degradation, the whole process is operated on ice. Thaw RIPA lysate and mix well. Take an appropriate amount of lysate, and add PMSF (protease inhibitor) within a few minutes before use, so that the final concentration of PMSF is 1 mM. Remove culture medium and wash three times with buffer. Add lysate according to the ratio of adding 40 microliters of lysate to each well of a 6-well plate, that is, add 100 microliters of lysate to each bottle of T25. Pipet several times with a gun to make the lysate fully contact with the cells. Mix and shake, place on ice to lyse, shake and mix repeatedly every 10 minutes, a total of 3 times. After fully lysed, centrifuge at 10,000 g for 5 minutes, and take 80 microliters of supernatant. Dissolve SDS-PAGE loading buffer (5X). Add 20 μl SDS-PAGE loading buffer (5X) to 80 μl lysate. Wherein, all required reagents RIPA lysate, PMSF, and SDS-PAGE loading buffer (5X) are commercially available.
(4)煮沸15分钟,使蛋白变性。冷却后放-20℃冻存。(4) Boil for 15 minutes to denature the protein. After cooling, store at -20°C.
(5)提取蛋白后,Western blot检测人脐带间充质干细胞中的β-actin,上样量均为20微升。(5) After protein extraction, Western blot was used to detect β-actin in human umbilical cord mesenchymal stem cells, and the loading volume was 20 microliters.
WB实验结果见图3。(1)传统方法按照以上步骤最佳情况6孔板每孔加入40微升裂解液,可得50微升样品,上样量20微升,即6孔板2孔最多可以做5次western。而本发明24孔板每孔可以做10次western。换算下来本发明只需传统方法八十分之一的蛋白量。(2)图3A是传统方式提取一个T25的蛋白和新方法提取24孔板一个孔的蛋白的β-actin的对比。传统方法和本发明方法收集细胞量的对比是10∶1。图3B是WB条带所含β-actin的灰度分析值。其数据说明本发明方法在细胞量只有传统方法的十分之一情况下,本发明提取蛋白质的β-actin表达量是传统方法的三倍以上。The results of the WB experiment are shown in Figure 3. (1) According to the traditional method, add 40 microliters of lysate to each well of a 6-well plate in the best case to obtain 50 microliters of samples, and the sample volume is 20 microliters, that is, 2 wells of a 6-well plate can be used for up to 5 westerns. However, each well of the 24-well plate of the present invention can perform 10 westerns. In conversion, the present invention only needs one-eightyth of the protein amount of the traditional method. (2) Figure 3A is a comparison between the traditional method of extracting a T25 protein and the new method of extracting β-actin from a well of a 24-well plate. The comparison of the amount of cells collected by the traditional method and the method of the present invention is 10:1. Figure 3B is the grayscale analysis value of β-actin contained in the WB strip. The data shows that the method of the present invention has only one-tenth of the cell mass of the traditional method, and the β-actin expression of the protein extracted by the present invention is more than three times that of the traditional method.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810577627.1A CN108727464A (en) | 2018-06-06 | 2018-06-06 | A kind of new Protein Extraction Reagent and method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810577627.1A CN108727464A (en) | 2018-06-06 | 2018-06-06 | A kind of new Protein Extraction Reagent and method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108727464A true CN108727464A (en) | 2018-11-02 |
Family
ID=63932675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810577627.1A Pending CN108727464A (en) | 2018-06-06 | 2018-06-06 | A kind of new Protein Extraction Reagent and method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108727464A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131439A (en) * | 1993-08-17 | 1996-09-18 | 莫根国际公司 | Chitinase DNA coding thereof and plants containing same |
CN101754976A (en) * | 2007-07-24 | 2010-06-23 | 保罗·普里米耶罗 | Complexes of Grp94 with human immunoglobulin G |
US20130219570A1 (en) * | 2009-04-17 | 2013-08-22 | Dow Agrosciences Llc | DIG-3 INSECTICIDAL Cry TOXINS |
-
2018
- 2018-06-06 CN CN201810577627.1A patent/CN108727464A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131439A (en) * | 1993-08-17 | 1996-09-18 | 莫根国际公司 | Chitinase DNA coding thereof and plants containing same |
CN101754976A (en) * | 2007-07-24 | 2010-06-23 | 保罗·普里米耶罗 | Complexes of Grp94 with human immunoglobulin G |
US20130219570A1 (en) * | 2009-04-17 | 2013-08-22 | Dow Agrosciences Llc | DIG-3 INSECTICIDAL Cry TOXINS |
Non-Patent Citations (4)
Title |
---|
H. SCHIECHL: "Isolation, chemical characterization, and immunohistochemical localization of a protein from the basolateral plasma membrane of the rat intestinal absorptive cell", 《Z NATURFORSCH C J BIOSCI》 * |
季一兵: "《中药毛细管电泳分析技术与应用》", 30 June 2009, 中国医药科技出版社 * |
钱士匀: "《分子诊断学实验指导》", 31 December 2006, 高等教育出版社 * |
陈中湘等: "含EGFP报告基因单顺反子HCV亚基因组复制子载体的构建和表达", 《中国病原生物学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hellewell et al. | A rapid, scalable method for the isolation, functional study, and analysis of cell-derived extracellular matrix | |
Durbin et al. | Quantitation and identification of thousands of human proteoforms below 30 kDa | |
Reichel et al. | Degradation of tobacco mosaic virus movement protein by the 26S proteasome | |
Garaud et al. | A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes | |
Bauer et al. | Determination of the carbon content of airborne fungal spores | |
Timaner et al. | Analysis of the stromal cellular components of the solid tumor microenvironment using flow cytometry | |
Morbeck et al. | Washing mineral oil reduces contaminants and embryotoxicity | |
Luo et al. | Photocatalytic chemical crosslinking for profiling RNA–protein interactions in living cells | |
Maundrell et al. | Characterization of pre‐messenger‐RNA‐containing nuclear ribonucleoprotein particles from avian erythroblasts | |
Teixeira et al. | A rapid and ultrasensitive method for measurement of DNA, calcium and protein content, and alkaline phosphatase activity of chondrocyte cultures | |
CN101180310A (en) | Extraction of proteins from formalin-fixed tissue | |
Bailleul et al. | DNA staining in fossil cells beyond the Quaternary: Reassessment of the evidence and prospects for an improved understanding of DNA preservation in deep time | |
Pirog et al. | Comparison of different digestion methods for proteomic analysis of isolated cells and FFPE tissue samples | |
CN108780086B (en) | Subcellular localization of target analytes | |
Guo et al. | Capture of the newly transcribed RNA interactome using click chemistry | |
Schultz et al. | Concurrent levels of 11‐ketotestosterone in fish surface mucus, muscle tissue and blood | |
CN108727464A (en) | A kind of new Protein Extraction Reagent and method | |
Zhang et al. | Identification of Prolificacy‐Related Differentially Expressed Proteins from Sheep (Ovis aries) Hypothalamus by Comparative Proteomics | |
CN101949931B (en) | Capillary electrophoresis electrochemical enzyme linked immunoassay for detecting amnesic shellfish toxicity | |
CN105784573A (en) | Method for analyzing wheat root tip cell cycle through flow cytometry | |
CN117230011A (en) | Construction method of ovarian boundary tumor organoid model | |
US20180282823A1 (en) | Molecular identification method for single dinoflagellate cyst | |
Lazarev et al. | Centrifugal methods and devices for rapid in‐gel digestion of proteins | |
Li et al. | Tandem affinity purification (TAP) of low-abundance protein complexes in filamentous fungi demonstrated using Magnaporthe oryzae | |
Hanin et al. | Mammary adipocyte flow cytometry as a tool to study mammary gland biology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181102 |
|
RJ01 | Rejection of invention patent application after publication |